Citations 4

Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer

JAMA Oncology | January 20, 2022 | Volume: 8 | Issue: 3 | Pages: e216871

10.1001/jamaoncol.2021.6871 | PMID 35050303

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

JAMA Network Open | December 13, 2021 | Volume: 4 | Issue: 12 | Pages: e2138550

10.1001/jamanetworkopen.2021.38550 | PMID 34902034

Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features

JAMA Network Open | July 1, 2021 | Volume: 4 | Issue: 7 | Pages: e2115312

10.1001/jamanetworkopen.2021.15312 | PMID 34196715

HSD3B1 and resistance to androgen deprivation therapy in prostate cancer.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5015-5015

10.1200/jco.2016.34.15_suppl.5015